Insilico Medicine
Develops AI-driven drug discovery and oncology treatments
$5MStrategic
Role not disclosedT
Temasek
Activity from announced rounds
Activity in this selectionFeb 28, 2026 · AI · Feb 1, 2026
Temasek is a Singapore investment company with global public and private holdings, investing around digitisation, sustainable living, the future of consumption and longer lifespans.
Its global direct investments target both emerging and established market leaders. The four structural themes cut across industries: AI and computing, renewable energy and industrial decarbonisation, changing consumer demand and health-related innovation.
Temasek’s portfolio also includes Singapore-based companies and partnerships with fund managers. Since April 2026, its organisational structure separates global direct investments, Singapore holdings and partnership solutions, giving these distinct investment activities dedicated teams.
Sources
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 1 First participation on record · 1 follow-on
- Funding in participating rounds
- $16B 2 disclosed · full round size, not this investor’s share